Home/Filings/4/0001104659-24-002518
4//SEC Filing

Krishnamurthy Nirup 4

Accession 0001104659-24-002518

CIK 0001622879other

Filed

Jan 8, 7:00 PM ET

Accepted

Jan 9, 11:40 AM ET

Size

7.8 KB

Accession

0001104659-24-002518

Insider Transaction Report

Form 4
Period: 2023-05-24
Krishnamurthy Nirup
Chief Operating Officer
Transactions
  • Award

    Common Stock

    2023-05-24+1,600,0001,600,000 total
  • Award

    Employee Stock Option (Right to Buy)

    2023-05-24+800,0002,000,000 total
    Exercise: $1.03Exp: 2033-05-24Common Stock (800,000 underlying)
Footnotes (3)
  • [F1]Issued as restricted stock units (RSUs) in connection with reporting persons retainer as director under the Company's 2017 Equity Incentive Plan and exempt from Section 16(b) by virtue of Rule 16(b)-b(d)(1) and (3). The RSU's are reportable, however, as directly owned shares of common stock, rather as a derivative security in Table II, because any and all underlying RSUs are payable, at such time as they are to be settled, solely in common stock. See Lincoln National Corp. (March 20, 1992) (Q.3).
  • [F2]The options vest in four (4) equal annual installments on each anniversary of the grant date, beginning on May 24, 2023.
  • [F3]The options vest in four (4) equal annual installments on each anniversary of the grant date, beginning on May 24, 2024.

Issuer

Medicine Man Technologies, Inc.

CIK 0001622879

Entity typeother

Related Parties

1
  • filerCIK 0001825865

Filing Metadata

Form type
4
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 11:40 AM ET
Size
7.8 KB